These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 2889251)

  • 21. Isoprenaline antagonism and duration of action in exercise induced tachycardia of three -adrenoceptor blocking drugs: pindolol, LF 17-895 and propranolol.
    Aellig WH
    Br J Pharmacol; 1973 Mar; 47(3):621P-622P. PubMed ID: 4147193
    [No Abstract]   [Full Text] [Related]  

  • 22. Plasma levels of mepindolol in healthy volunteers after oral doses of mepindolol sulphate.
    Krause W; Schwartzkopff W
    Arzneimittelforschung; 1983; 33(9):1306-7. PubMed ID: 6685513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of the new beta-adrenoceptor blocking agent betaxolol (SL 75212) in man after repeated oral administration.
    Bianchetti G; Blatrix C; Gomeni R; Kilborn JR; Larribaud J; Lücker PW; Thebault JJ; Trocherie S; Morselli PL
    Arzneimittelforschung; 1980; 30(11):1912-6. PubMed ID: 6109538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Beta adrenolytic activity and hemodynamic effects of penbutolol].
    Boissier JR; Coutte R; Advenier C; Giudicelli JF
    Therapie; 1973; 28(6):1251-65. PubMed ID: 4152643
    [No Abstract]   [Full Text] [Related]  

  • 25. An echocardiographic study of interactions between pindolol and epinephrine contained in a local anesthetic solution.
    Sugimura M; Hirota Y; Shibutani T; Niwa H; Hori T; Kim Y; Matsuura H
    Anesth Prog; 1995; 42(2):29-35. PubMed ID: 8934951
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of beta-blockers on plasma lipids.
    Pasotti C; Zoppi A; Capra A; Rebagliati M; Fogari R
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):448-52. PubMed ID: 3759280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute and chronic effects of the beta-receptor blocker mepindolol on hemodynamics and the portal circulation.
    Wink K
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):477-50. PubMed ID: 6490229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive estimates of the inodilatory effects of isoprenaline and their inhibition by transdermally delivered mepindolol in healthy men.
    de Mey C; Enterling D
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):358-66. PubMed ID: 1279279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cardiovascular effects of acebutolol (M & B 17803A), in exercising man; a comparative study with practolol and propranolol.
    Coleman AJ; Leary WP
    Curr Ther Res Clin Exp; 1972 Oct; 14(10):673-8. PubMed ID: 4404477
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical pharmacology of the beta-adrenolytic activity of pindolol].
    Hugues FC; Julien D; Munera Y; Heams D; Marche J
    Therapie; 1976; 31(2):179-93. PubMed ID: 7858
    [No Abstract]   [Full Text] [Related]  

  • 34. The interaction between pindolol and epinephrine contained in local anesthetic solution to the left ventricular diastolic filling velocity in normal subjects.
    Niwa H; Shibutani T; Hori T; Kim Y; Akita M; Matsuura H
    Anesth Prog; 1996; 43(3):78-84. PubMed ID: 10323111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bopindolol: a new long acting beta-receptor antagonist; its effects on haemodynamics, and on the renin response to tilting.
    Turner DR; Goodwin FJ; Knight AR; Littlejohns DW; Sharman VL; Vere DW
    Br J Clin Pharmacol; 1984 Mar; 17(3):295-9. PubMed ID: 6143566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioequivalence of two oral immediate release formulations of pindolol in healthy volunteers assessed by ratio analysis.
    Koch HJ; Raschka C; Hannak D
    Acta Physiol Pharmacol Bulg; 2000; 25(3-4):99-102. PubMed ID: 11688554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the short-term effects of mepindolol and propranolol on splanchnic and systemic haemodynamics in patients with cirrhosis.
    Braillon A; Calès P; Lebrec D
    Int J Clin Pharmacol Res; 1985; 5(4):223-8. PubMed ID: 4055165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of various beta adrenolytic agents on the alpha blocking properties of yohimbine in the dog].
    Mouillé P; Cheymol G
    C R Seances Soc Biol Fil; 1973; 167(3):440-2. PubMed ID: 4150410
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.